scholarly journals Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

2010 ◽  
Vol 103 (7) ◽  
pp. 1008-1018 ◽  
Author(s):  
J Hao ◽  
H Chen ◽  
M C Madigan ◽  
P J Cozzi ◽  
J Beretov ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Resistance ◽  
Cancer Drug ◽  
Monocarboxylate Transporters ◽  
Cancer Drug Resistance

scholarly journals Abstract LB-030: Interferon signaling contributes to prostate cancer drug resistance

2019 ◽  
Author(s):  
Supreet Agarwal ◽  
Kerry McGowen ◽  
Fathi Elloumi ◽  
Maggie Cam ◽  
Mike Beshiri ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Resistance ◽  
Cancer Drug ◽  
Interferon Signaling ◽  
Cancer Drug Resistance

Liquid biopsy: Clues on prostate cancer drug resistance

2015 ◽  
Vol 7 (312) ◽  
pp. 312fs45-312fs45 ◽  
Author(s):  
Michael T. Schweizer ◽  
Emmanuel S. Antonarakis
Keyword(s):  
Prostate Cancer ◽  
Drug Resistance ◽  
Liquid Biopsy ◽  
Cancer Drug ◽  
Cancer Drug Resistance

scholarly journals Abstract LB-030: Interferon signaling contributes to prostate cancer drug resistance

2019 ◽  
Author(s):  
Supreet Agarwal ◽  
Kerry McGowen ◽  
Fathi Elloumi ◽  
Maggie Cam ◽  
Mike Beshiri ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Resistance ◽  
Cancer Drug ◽  
Interferon Signaling ◽  
Cancer Drug Resistance

scholarly journals Overcoming prostate cancer drug resistance with a novel organosilicon small molecule

Neoplasia ◽  
2021 ◽  
Vol 23 (12) ◽  
pp. 1261-1274
Author(s):  
Rui Zhao ◽  
Xiaowei Ma ◽  
Lijuan Bai ◽  
Xin Li ◽  
Kenza Mamouni ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Resistance ◽  
Small Molecule ◽  
Cancer Drug ◽  
Cancer Drug Resistance

Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance

2020 ◽  
Vol 20 (9) ◽  
pp. 779-787
Author(s):  
Kajal Ghosal ◽  
Christian Agatemor ◽  
Richard I. Han ◽  
Amy T. Ku ◽  
Sabu Thomas ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Dna Repair ◽  
Fanconi Anemia ◽  
Cancer Drug ◽  
Drug Resistant ◽  
Cancer Drugs ◽  
Repair Pathway ◽  
Cancer Drug Resistance ◽  
Anti Cancer ◽  
Cancerous Cells

Chemotherapy employs anti-cancer drugs to stop the growth of cancerous cells, but one common obstacle to the success is the development of chemoresistance, which leads to failure of the previously effective anti-cancer drugs. Resistance arises from different mechanistic pathways, and in this critical review, we focus on the Fanconi Anemia (FA) pathway in chemoresistance. This pathway has yet to be intensively researched by mainstream cancer researchers. This review aims to inspire a new thrust toward the contribution of the FA pathway to drug resistance in cancer. We believe an indepth understanding of this pathway will open new frontiers to effectively treat drug-resistant cancer.

Sign in / Sign up

Export Citation Format

Share Document